Many groups have reported on the interplay between p53 and the interferon response; indeed, the ability of HSV1716 and many other OVs to selectively infect malignant cells is predicated on aberrant antiviral responses in cancer cells [48,49,50,51]. This evidence concerns the gene TP53 and cancer.